Brenda Muth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brenda Muth has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Didier A. Mandelbrot
Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
3 shared publications - Sandesh Parajuli
Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
3 shared publications Arjang Djamali
Division of Nephrology Department of Medicine University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA
2 shared publicationsDixon Kaufman
Division of Transplant Surgery University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA
2 shared publications- Fahad Aziz
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
2 shared publications Maha Mohamed
Division of Nephrology Department of Medicine University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA
2 shared publications
Latest Publications
- Open Access
- 17 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15197
Risk factors and outcomes of persistent post‐transplant hypotension among simultaneous pancreas and kidney transplant recipients
Background: The risk factors and outcomes associated with post‐ transplant hypotension after simultaneous pancreas and kidney (SPK) Transplantation are poorly defined.Methods: SPK recipients at our center between 2010 and 2021 with functioning pancreas and kidney grafts for >6 months were included. Recipients were then divided into three groups based on active medications for the treatment of hypo‐or hypertension at 6‐months post‐transplant: those with normal blood pressure (NBP) not requiring medication (NBP group), those on antihypertensive medications (HTN group), and those on medications for hypotension (fludrocortisone and/or midodrine) (Hypotensive group).Results: A total of 306 recipients were included in the study: 54 (18%) in the NBP group, 215 (70%) in the HTN group, and 37 (12%) in the Hypotensive group. On multivariate analysis, the use of T‐depleting induction (aHR = 9.64, p = .0001, 95% Cl = 3.12–29.75), pre‐transplant use of hypotensive medications (aHR = 4.53, p = .0003, 95% Cl = 1.98–10.38), and longer duration of dialysis (aHR = 1.02, p = .01, 95% Cl = 1.00–1.04) were associated with an increased risk of post‐transplant hypotension. Post‐transplant hypotension was not associated with an increased risk of death‐censored kidney or pancreatic allograft failure, or patient death.Conclusion: Hypotension was common even 6 months post‐SPK transplantation. With appropriate management, hypotension was not associated with detrimental graft or patient outcomes.
- 17 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15197
Open AccessRisk factors and outcomes of persistent post‐transplant hypotension among simultaneous pancreas and kidney transplant recipients
Background: The risk factors and outcomes associated with post‐ transplant hypotension after simultaneous pancreas and kidney (SPK) Transplantation are poorly defined.Methods: SPK recipients at our center between 2010 and 2021 with functioning pancreas and kidney grafts for >6 months were included. Recipients were then divided into three groups based on active medications for the treatment of hypo‐or hypertension at 6‐months post‐transplant: those with normal blood pressure (NBP) not requiring medication (NBP group), those on antihypertensive medications (HTN group), and those on medications for hypotension (fludrocortisone and/or midodrine) (Hypotensive group).Results: A total of 306 recipients were included in the study: 54 (18%) in the NBP group, 215 (70%) in the HTN group, and 37 (12%) in the Hypotensive group. On multivariate analysis, the use of T‐depleting induction (aHR = 9.64, p = .0001, 95% Cl = 3.12–29.75), pre‐transplant use of hypotensive medications (aHR = 4.53, p = .0003, 95% Cl = 1.98–10.38), and longer duration of dialysis (aHR = 1.02, p = .01, 95% Cl = 1.00–1.04) were associated with an increased risk of post‐transplant hypotension. Post‐transplant hypotension was not associated with an increased risk of death‐censored kidney or pancreatic allograft failure, or patient death.Conclusion: Hypotension was common even 6 months post‐SPK transplantation. With appropriate management, hypotension was not associated with detrimental graft or patient outcomes.
- Open Access
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (3) , 408-415
The current state of transplant advanced practice providers: results of the advanced practice provider practice survey
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (3) , 408-415
Open AccessThe current state of transplant advanced practice providers: results of the advanced practice provider practice survey
- 27 July 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (9) , e14779
In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes
Introduction: Delayed graft function (DGF) is a common complication among deceased donor kidney transplant recipients (DDKTs) and is associated with worse outcomes. The effect on outcomes of concordance versus discordance in DGF between two different recipients of kidneys from the same donor is largely unknown.Methods: We reviewed all adult DDKTs for which both kidneys were transplanted to two different recipients at our center between 2014–2019. DDKTs were divided into four groups based on the DGF status: concordance no DGF (cc‐no‐DGF); discordance no DGF(dd‐no‐DGF); discordance DGF (dd‐DGF) and concordance in DGF (cc‐DGF). Acute rejection (AR) and death censored graft failure (DCGF) were outcomes of interest.Results: A total of 578 DDKTs fulfilled our selection criteria, 280were in cc‐no‐DGF, 83 in dd‐no‐DGF, 83 in dd‐DGF, and 132 in cc‐DGF. Compared to cc‐no‐DGF, in univariate analysis, dd‐DGF was associated with an increased risk of AR (HR: 1.60; 95% CI: 1.0‐2.56) but cc‐DGF was not (HR: 1.01; 95% CI: 0.63‐1.62). dd‐DGF was not associated with an increased risk of AR in multivariate analysis. In multivariate analysis, dd‐DGF was associated with an increased risk of DCGF (HR: 2.70; 95% CI: 1.05‐6.93) but cc‐DGFwas not (HR: 2.36; 95% CI: 0.97‐5.70).Conclusion: Discordance in DGF is associated with worse outcomes and may need closefollow‐up and monitoring to improve the outcomes.
- 27 July 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (9) , e14779
In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes
Introduction: Delayed graft function (DGF) is a common complication among deceased donor kidney transplant recipients (DDKTs) and is associated with worse outcomes. The effect on outcomes of concordance versus discordance in DGF between two different recipients of kidneys from the same donor is largely unknown.Methods: We reviewed all adult DDKTs for which both kidneys were transplanted to two different recipients at our center between 2014–2019. DDKTs were divided into four groups based on the DGF status: concordance no DGF (cc‐no‐DGF); discordance no DGF(dd‐no‐DGF); discordance DGF (dd‐DGF) and concordance in DGF (cc‐DGF). Acute rejection (AR) and death censored graft failure (DCGF) were outcomes of interest.Results: A total of 578 DDKTs fulfilled our selection criteria, 280were in cc‐no‐DGF, 83 in dd‐no‐DGF, 83 in dd‐DGF, and 132 in cc‐DGF. Compared to cc‐no‐DGF, in univariate analysis, dd‐DGF was associated with an increased risk of AR (HR: 1.60; 95% CI: 1.0‐2.56) but cc‐DGF was not (HR: 1.01; 95% CI: 0.63‐1.62). dd‐DGF was not associated with an increased risk of AR in multivariate analysis. In multivariate analysis, dd‐DGF was associated with an increased risk of DCGF (HR: 2.70; 95% CI: 1.05‐6.93) but cc‐DGFwas not (HR: 2.36; 95% CI: 0.97‐5.70).Conclusion: Discordance in DGF is associated with worse outcomes and may need closefollow‐up and monitoring to improve the outcomes.
- 31 October 2018
- Published by Springer Nature
- p. 43-53
Post Kidney Transplant Immediate Complications: Delayed Graft Function and Wound
- 31 October 2018
- Published by Springer Nature
- p. 43-53
Post Kidney Transplant Immediate Complications: Delayed Graft Function and Wound
- 2 February 2018
- Published by Wiley in Clinical Transplantation
- Vol. 32 (4) , e13216
Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?
Little data exist comparing outcomes following BK nephropathy (BKN) vs acute rejection. We reviewed outcomes among recipients who had a primary diagnosis of biopsy‐proven BKN or rejection between 1 and 18 months post‐transplant. There were 96 cases of BKN and 256 cases of rejections. We compared outcomes of BKN with all rejection combined and also with cellular rejection. Seven of 256 (2.7%) patients developed BKN after treatment of rejection. Conversely, 8 of 96 (8.3%) developed rejection after BKN. The eGFR at time of diagnosis in the BKN group (33.7 ± 12.6) was lower than the rejection group (44.8 ± 23.3, P < .001). The eGFR at 6 months after diagnosis of BKN was 32.7 ± 14.9 and for rejection was 48.8 ± 20.7 (P ≤ .001). The mean eGFR at 3 years postdiagnosis was 41.6 ± 18.5 in BKN and 53 ± 21.3 for rejection (P = .001). The graft failure incidence rates were similar between 2 groups. A similar pattern was observed comparing BKN with cellular rejection. While the difference in rate of graft loss between BKN and rejection did not reach statistical significance, kidney function up to 3 years after diagnosis was worse for BKN than for rejection, suggesting that BKN is at least as damaging to kidneys as rejection.
- 2 February 2018
- Published by Wiley in Clinical Transplantation
- Vol. 32 (4) , e13216
Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?
Little data exist comparing outcomes following BK nephropathy (BKN) vs acute rejection. We reviewed outcomes among recipients who had a primary diagnosis of biopsy‐proven BKN or rejection between 1 and 18 months post‐transplant. There were 96 cases of BKN and 256 cases of rejections. We compared outcomes of BKN with all rejection combined and also with cellular rejection. Seven of 256 (2.7%) patients developed BKN after treatment of rejection. Conversely, 8 of 96 (8.3%) developed rejection after BKN. The eGFR at time of diagnosis in the BKN group (33.7 ± 12.6) was lower than the rejection group (44.8 ± 23.3, P < .001). The eGFR at 6 months after diagnosis of BKN was 32.7 ± 14.9 and for rejection was 48.8 ± 20.7 (P ≤ .001). The mean eGFR at 3 years postdiagnosis was 41.6 ± 18.5 in BKN and 53 ± 21.3 for rejection (P = .001). The graft failure incidence rates were similar between 2 groups. A similar pattern was observed comparing BKN with cellular rejection. While the difference in rate of graft loss between BKN and rejection did not reach statistical significance, kidney function up to 3 years after diagnosis was worse for BKN than for rejection, suggesting that BKN is at least as damaging to kidneys as rejection.
- Open Access
- 24 December 2015
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (5) , 1604-1611
Outpatient Management of Delayed Graft Function Is Associated With Reduced Length of Stay Without an Increase in Adverse Events
- 24 December 2015
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (5) , 1604-1611
Open AccessOutpatient Management of Delayed Graft Function Is Associated With Reduced Length of Stay Without an Increase in Adverse Events
- Open Access
- 23 November 2009
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (4) , 1300-1306
Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival
Background. There is no information on the effects of proteinuria on outcomes following rejection.
- 23 November 2009
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (4) , 1300-1306
Open AccessIncrease in proteinuria >200 mg/g after late rejection is associated with poor graft survival
Background. There is no information on the effects of proteinuria on outcomes following rejection.